Steris PLC (STE) News

Steris PLC (STE): $170.19

-2.55 (-1.48%)

POWR Rating

Component Grades













Filter STE News Items

STE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

STE News Highlights

  • STE's 30 day story count now stands at 4.
  • Over the past 28 days, the trend for STE's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about STE are COOK, ID and SHC.

Latest STE News From Around the Web

Below are the latest news stories about STERIS PLC that investors may wish to consider to help them evaluate STE as an investment opportunity.

Got $3,000? Here Are 2 Stocks That Will Make You Richer

BioCryst Pharmaceuticals and Steris could both deliver outstanding returns for patient shareholders.

Yahoo | October 2, 2022

Needham Keeps Their Hold Rating on Steris (STE)

E ratio of 47.25.

Catie Powers on TipRanks | September 23, 2022

Needham Downgrades This Medical Equipment Stock Due To Lawsuit Risk

A Cook County jury awarded $363 million to a woman who developed breast cancer after living close to a medical device sterilization facility run by Sterigenics, a unit of Sotera Health Co (NASDAQ: SHC). The lawsuit was related to ethylene oxide (EO) exposure, a disinfectant used to sterilize medical devices. The trial was the first of many to come against the Willowbrook plant operators, with more than 760 lawsuits against it in Cook County Circuit Court for toxic emissions. Needham expects conc

Yahoo | September 23, 2022

Steris: Non-GAAP Valuations Supportive Of Substantial Upside


Hummingbird Insights LP on Seeking Alpha | September 4, 2022

Steris (STE) Down 0.8% Since Last Earnings Report: Can It Rebound?

Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 1, 2022

STERIS' (NYSE:STE) Upcoming Dividend Will Be Larger Than Last Year's

The board of STERIS plc ( NYSE:STE ) has announced that it will be increasing its dividend by 9.3% on the 23rd of...

Yahoo | August 18, 2022

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS' (STE) robust segmental performance and Cantel Medical buyout.

Yahoo | August 17, 2022

STERIS (STE) Gains From Cantel Buyout, Supply Chain Issue Stays

Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.

Yahoo | August 12, 2022

Needham Sticks to Its Buy Rating for Steris (STE)

Needham analyst Michael Matson maintained a Buy rating on Steris (STE – Research Report) today and set a price target of $237.00. The company's shares closed last Wednesday at $203.81. According to, Matson is a 4-star analyst with an average return of 3.8% and a 48.2% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Steris with a $248.00 average price target, implying a 14.0% upside from current levels.

Christine Brown on TipRanks | August 3, 2022

STERIS (STE) Q1 Earnings Match Estimates, EPS View Down

STERIS' (STE) revenues at AST improve driven by increased demand from medical device and biopharma customers.

Yahoo | August 3, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5439 seconds.